论文部分内容阅读
目的探讨应用阿希米治疗120例宫颈糜烂的临床疗效。方法将我院2012年1～6月收治的120例宫颈糜烂患者随机分为对照组和治疗组。其中对照组60例患者采用复方甲硝唑常规治疗,治疗组60例患者则采用阿希米治疗。治疗时间均为两个疗程,观察治疗效果及不良反应。结果阿希米治疗组和复方甲硝唑对照组的患者痊愈率和显效率明显提高(P<0.05),有效率分别98.33%和80.00%,(χ2=10.4385,P<0.05),差异显著。结论阿希米治疗宫颈糜烂的痊愈率,显效率明显提高,且总有效率高,值得临床推广使用。
Objective To investigate the clinical efficacy of apiximi in the treatment of 120 cases of cervical erosion. Methods One hundred and twenty patients with cervical erosion admitted to our hospital from January to June in 2012 were randomly divided into control group and treatment group. The control group of 60 patients with conventional metronidazole compound treatment, the treatment group of 60 patients were treated with Asimi. Treatment time are two courses to observe the therapeutic effect and adverse reactions. Results The cure rate and markedly effective rate were significantly higher in the patients treated with amiloride and metronidazole (P <0.05), and the effective rates were 98.33% and 80.00%, respectively (χ2 = 10.4385, P <0.05). Conclusion Asimi treatment of cervical erosion cure rate, significant efficiency was significantly improved, and the total effective rate, worthy of clinical promotion and use.